跳至主要内容
临床试验/EUCTR2013-001093-16-IS
EUCTR2013-001093-16-IS进行中(未招募)1 期

Comparison of non-MMC trabeculectomy and dexamethasone nanoparticles eye drops with MMC trabeculectomy and Maxidex®

Oculis ehf.0 个研究点开始时间: 2013年6月18日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
Oculis ehf.

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Inclusion criteria
  • -Patients with a diagnosis of glaucoma that are scheduled to undergo glaucoma surgery
  • -18-85 years of age
  • -Signed informed consent form
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 15

排除标准

  • Exclusion criteria
  • -Any active ocular disease or infection
  • -Those allergic to study medications
  • -Pregnant women and breastfeeding women
  • -Those unable to understand the informed consent
  • -Those that have participated in any clinical study for the last six months

研究者

发起方
Oculis ehf.

相似试验